Analysis of the additional data and information submitted by Bharat Biotech and Serum Institute of India (SII) is still being conducted by the regulator Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee.
Russian scientists from Kaliningrad and St. Petersburg have synthesized nitrogen-containing cyclic compounds that differ only in the relative position of side substituents that can be used for treating resistant-bacteria.
Chiari 1 malformation may run in families, but scientists knew little about the alterations that contribute to the condition. New study throws light on roots or genetic alterations responsible for this malformation.
Testing for primary aldosteronism in patients with treatment-resistent hypertension was rare and also linked with higher rates of evidence-based treatment and better longitudinal blood pressure control.
Study led by Singapore clinician-scientists has found a way to classify angiosarcomas into three subtypes, allowing for more targeted treatment, better outcomes for patients and the development of new therapies.